Post-marketing Study of Linagliptin: A Pilot Study

INTRODUCTION: Linagliptin is a high-cost oral antidiabetic that has been widely used, and studies on its effectiveness and safety for the treatment of type 2 diabetes mellitus (DM2) in the real world is rare and necessary. OBJECTIVE: To analyze the values of glycated hemoglobin (HbA1c) and adverse e...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomes, Gabrielle Kéfrem Alves, Pereira, Mariana Linhares, Sanches, Cristina, Baldoni, André Oliveira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543281/
https://www.ncbi.nlm.nih.gov/pubmed/31178735
http://dx.doi.org/10.3389/fphar.2019.00576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543281/
https://www.ncbi.nlm.nih.gov/pubmed/31178735
http://dx.doi.org/10.3389/fphar.2019.00576

Ejemplares similares